Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial (Q44611376)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2003

Language	Label	Description	Also known as
English	Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial	scientific article published in October 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

zoledronic acid

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Lee S Rosen

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

David Gordon

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Mary Kaminski

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Andrew Belch

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

John Mackey

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Justus Apffelstaedt

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Mohamad A Hussein

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Robert E Coleman

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Dirk J Reitsma

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Bee-Lian Chen

11

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

John J Seaman

12

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1735-1744

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant bone pain: pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Nontraditional cytotoxic therapies for relapsed/refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of skeletal complications in patients with metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in supportive care of patients with cancer and bone metastases: nursing implications of zoledronic acid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Cox's Regression Model for Counting Processes: A Large Sample Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonates in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11701

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.11701

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44611376&oldid=2070304430"